Description
The clinic that never generates a dramatic case
Preventive work is the least visible cardiology there is. Nothing happens, which is the point, and which is also why it attracts less teaching, less protocol and less clinician confidence than any acute presentation. Most of it is delivered by general physicians and family doctors rather than cardiologists.
This collection is a working reference for that clinic.
Where the calculators fail
Substantial attention goes to the limits of risk scores, because a physician applying them outside their derivation population is doing something the score does not support. Age extremes are covered, and so are South Asian populations, where conventional stratification systematically under-calls risk — relevant to a large share of our directory.
Practical coverage
Lipid management through first-line therapy, residual risk and Lp(a). Hypertension across the treatment sequence, including resistant cases. Diabetes and obesity where they alter cardiovascular outcome rather than glycaemia alone. Inflammation. Smoking, alcohol, sleep and activity.
Adherence
Given its own treatment, on the practical argument that a correct prescription not taken is a clinical failure regardless of how well it was chosen. Clinicians consistently rate this the most immediately applicable section.
Suits
General physicians, family doctors, cardiologists running risk clinics, diabetologists, and preventive health services.
PDF collection, lifetime access, from CardiologyBooks.com.
Prevention as a clinic workflow
This preventive cardiology reference treats risk reduction as something that has to fit inside a twelve-minute consultation, not as an ideal to be described. Risk estimation, lipid targets, blood pressure thresholds, glycaemic agents with cardiovascular benefit, and the conversation that actually changes behaviour are each reduced to what can be done at the visit in front of you.
Where the evidence is honest about uncertainty
The collection is explicit where guidelines diverge or where the trial population does not resemble the patient in the room: the older patient with a competing risk, the South Asian patient whose risk score under-reads, the patient already intolerant of two statins. Escalation and de-escalation are both covered, because stopping a drug well is a skill that preventive texts routinely omit.
